Erik Stomrud
141 – 150 of 189
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- Contribution to journal › Article
- 2019
-
Mark
Staging β -Amyloid Pathology with Amyloid Positron Emission Tomography
- Contribution to journal › Article
-
Mark
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
- Contribution to journal › Article
-
Mark
Determining clinically meaningful decline in preclinical Alzheimer disease
- Contribution to journal › Article
-
Mark
β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly
- Contribution to journal › Article
-
Mark
Towards a unified protocol for handling of CSF before β-amyloid measurements
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
- Contribution to journal › Article
